Informazioni su Inovio Pharmaceuticals, Inc. - Common Stock Panoramica della società da Wikipedia

Inovio Pharmaceuticals è un'azienda statunitense di biotecnologie fondata nel 1983, con sede a Plymouth Meeting in Pennsylvania. Quotata al NASDAQ, è attiva nella ricerca e nello sviluppo di prodotti a base di DNA sintetico per il trattamento di tumori e malattie infettive e nei vaccini.

Inovio Pharmaceuticals è un'azienda statunitense di biotecnologie fondata nel 1983, con sede a Plymouth Meeting in Pennsylvania. Quotata al NASDAQ, è attiva nella ricerca e nello sviluppo di prodotti a base di DNA sintetico per il trattamento di tumori e malattie infettive e nei vaccini.

Fonte: Wikipedia, CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

INO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$1.24

Capitalizzazione di Mercato

$85M

P/E (TTM)

-0.7

EPS (TTM)

$-1.81

Ricavi (TTM)

$65.3K

Rendimento div.

—

ROE

-322.8%

D/E Debito/Patrimonio

—

Intervallo 52 sett.

$1 – $3

INO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $65.3K

2016-12-31 → 2025-12-31

EPS $-1.81

2016-12-31 → 2025-12-31

Flusso di cassa libero $-89M

2016-12-31 → 2025-12-31

Margini -130000.0%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

INO

Mediana dei peer

P/E (TTM)

-0.7

0.8

P/S (TTM)

1304.1

423.1

P/B

3.5

5.5

Price / FCF (Prezzo / FCF)

-1.0

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

INO

Mediana dei peer

Operating Margin (Margine Operativo)

-132871.3%

—

Net Profit Margin (Margine di Profitto Netto)

-130000.0%

-3742.1%

ROA

-90.6%

-49.4%

ROE

-322.8%

-59.3%

ROIC

-360.3%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

INO

Mediana dei peer

Current Ratio (Rapporto corrente)

1.4

4.9

Quick Ratio

1.3

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

INO

Mediana dei peer

Revenue YoY (Ricavi YoY)

-70.0%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

-81.5%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

-61.2%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

INO

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-1.81

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

INO

Mediana dei peer

INO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 8 analisti

Acquisto forte 1 12,5%
Compra 4 50,0%
Mantieni 3 37,5%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

3 analisti · 2026-08-18

Mediana $3.00

Media $3.17

← Sotto tutti i target $1.24

Basso $2.50

Alto $4.00

Target mediano $3.00 +142,9%

Target medio $3.17 +156,4%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.08%

Periodo	EPS Actual	EPS Stimato	Sorpresa
31 Marzo 2026	$-0.28	$-0.35	0.07%
31 Dicembre 2025	$0.06	$-0.36	0.42%
30 Settembre 2025	$-0.87	$-0.43	-0.44%
30 Giugno 2025	$-0.61	$-0.62	0.01%
31 Marzo 2025	$-0.41	$-0.75	0.34%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
INO	$120M	-1.0	-70.0%	-130000.0%	-322.8%	—
VTVT	—	—	—	—	-70.4%	—
GNLX	$166M	-5.1	0.00%	-401812.5%	-181.4%	—
BDTX	$139M	6.2	—	31.9%	18.3%	—
ANIX	$136M	-12.1	0.00%	—	-62.2%	—
XGN	$139M	-6.5	19.7%	-30.0%	-103.7%	58.3%
COYA	$121M	-4.6	123.6%	-267.1%	-59.5%	—
CADL	$310M	-7.8	—	—	-53.7%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$65.3K	$217.8K	$832.0K	$10M	$2M	$7M	$4M	$30M	$42M	$35M	$41M	$10M
R&D Expense	$54M	$76M	$87M	$188M	$249M	$94M	$88M	$95M	$99M	$89M	$58M	$34M
SG&A Expense	$33M	$37M	$48M	$90M	$54M	$37M	$27M	$29M	$28M	$24M	$18M	$16M
Operating Expenses	$87M	$113M	$145M	$278M	$303M	$131M	$115M	$125M	$126M	$112M	$75M	$50M
Operating Income	$-87M	$-112M	$-144M	$-268M	$-301M	$-124M	$-111M	$-94M	$-84M	$-76M	$-34M	$-39M
Interest Expense	·	·	$1M	$1M	$2M	$9M	$8M	$0	$25.9K	·	·	·
Interest Income	$2M	$5M	$8M	$5M	$3M	$3M	$3M	$2M	$2M	·	·	·
Other Non-op	$-3M	$-3M	$-5M	$-4M	$343.4K	$-704.9K	$496.2K	$-1M	$-197.5K	·	·	·
Pretax Income	$-85M	$-107M	$-135M	$-278M	$-303M	$-163M	$-121M	$-95M	$-88M	$-74M	$-31M	$-36M
Income Tax	$0	$0	$0	$0	$0	$0	$-257.3K	$2M	$0	$0	$-2M	$0
Net Income	$-85M	$-107M	$-135M	$-280M	$-304M	$-166M	$-119M	$-97M	$-88M	$-74M	$-29M	$-36M
EPS (Basic)	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45	$-1.07	$-1.21	$-1.05	$-1.08	$-1.01	$-0.43	$-0.61
EPS (Diluted)	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45	$-1.07	$-1.21	$-1.05	$-1.09	$-1.01	$-0.44	$-0.64
Shares (Basic)	46,886,413	27,160,863	22,173,662	19,885,182	17,402,483	155,126,857	98,717,999	92,539,997	81,777,493	73,214,766	68,198,142	59,127,349
Shares (Diluted)	46,886,413	27,160,863	22,173,662	19,885,182	17,402,483	155,126,857	98,717,999	92,539,997	81,918,022	73,214,766	68,365,265	59,408,252
EBITDA	$-87M	$-112M	$-144M	$-268M	$-301M	$-124M	$-111M	$-94M	$-84M	$-76M	$-34M	$-39M

Stato Patrimoniale 27

Dati annuali Stato Patrimoniale per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$44M	$66M	$14M	$46M	$71M	$251M	$22M	$24M	$24M	$19M	$58M	$41M
Short-term Investments	$14M	$28M	$131M	$207M	$330M	$161M	$67M	$58M	$104M	$86M	$105M	$53M
Receivables	$450	$1M	$2M	$2M	$5M	$19M	$700.1K	$3M	$6M	$16M	$7M	$3M
Prepaid Expense	$3M	$4M	$5M	$50M	$39M	$40M	$2M	$1M	$3M	$2M	$917.3K	$798.0K
Current Assets	$61M	$98M	$153M	$315M	$448M	$471M	$94M	$88M	$138M	$125M	$172M	$99M
PP&E (Net)	$3M	$4M	$5M	$8M	$17M	$11M	$13M	$16M	$18M	$9M	$7M	$5M
PP&E (Gross)	$20M	$20M	$26M	$29M	$36M	$27M	$26M	$26M	$25M	$14M	$11M	$7M
Accum. Depreciation	$17M	$16M	$21M	$22M	$19M	$16M	$13M	$10M	$7M	$5M	$4M	$3M
Goodwill	·	·	$0	$11M	$11M	$11M	$11M	$11M	$11M	$11M	$10M	$10M
Intangibles	·	·	$0	$2M	$3M	$3M	$4M	$5M	$6M	$8M	$4M	$5M
Other Non-current Assets	$2M	$2M	$605.3K	$684.0K	$1M	$26M	$3M	$3M	$3M	$2M	$670.8K	$474.6K
Total Assets	$74M	$113M	$171M	$349M	$496M	$540M	$144M	$131M	$187M	$174M	$214M	$132M
Accounts Payable	·	·	·	$80M	$48M	$21M	$18M	$23M	$23M	$20M	$13M	$6M
Accrued Liabilities	·	·	·	·	·	·	·	$6M	$9M	$6M	$3M	$2M
Current Liabilities	$44M	$35M	$43M	$97M	$66M	$42M	$32M	$35M	$35M	$44M	$31M	$14M
Capital Leases	$7M	$9M	$11M	$13M	$15M	$18M	$20M	·	·	·	·	·
Deferred Tax	·	·	$0	$32.0K	$32.0K	$32.0K	$32.0K	$24.8K	$24.8K	$174.8K	$175.6K	$504.0K
Other Non-current Liabilities	·	·	·	$0	$14.8K	$57.7K	$36.9K	$87.3K	$0	·	·	·
Total Liabilities	$50M	$45M	$54M	$126M	$96M	$79M	$139M	$44M	$45M	$50M	$38M	$20M
Long-term Debt	·	·	·	·	·	·	·	$0	·	·	·	·
Common Stock	$69.0K	$36.1K	$22.8K	$21.1K	$217.4K	$186.9K	$101.4K	$97.2K	$90.4K	$74.1K	$72.2K	$60.7K
Paid-in Capital	$1.84B	$1.80B	$1.74B	$1.71B	$1.61B	$1.37B	$743M	$708M	$666M	$557M	$534M	$443M
Retained Earnings	$-1.82B	$-1.73B	$-1.62B	$-1.49B	$-1.21B	$-906M	$-740M	$-620M	$-523M	$-435M	$-361M	$-332M
AOCI	$-638.0K	$-675.7K	$-662.6K	$-698.7K	$-282.2K	$-256.1K	$472.6K	$-528.9K	$-117.0K	$1M	$3M	$-251.4K
Stockholders' Equity	$24M	$69M	$117M	$222M	$400M	$461M	$3M	$87M	$142M	$123M	$176M	$111M
Liabilities + Equity	$74M	$113M	$171M	$349M	$496M	$540M	$144M	$131M	$187M	$174M	$214M	$132M
Shares Outstanding	68,996,647	36,099,991	22,793,075	21,090,938	217,382,887	186,851,493	101,361,034	97,225,810	90,357,644	74,062,370	72,217,965	60,741,082

Flusso di cassa 14

Dati annuali Flusso di cassa per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Stock-based Comp	$4M	$7M	$11M	$23M	$26M	$16M	$11M	$11M	$13M	$10M	$6M	$5M
Deferred Tax	·	$0	$-32.0K	$0	$0	$0	$-263.0K	$0	$0	$0	$-2M	$27.0K
Amort. of Intangibles	·	$0	$145.4K	$496.5K	$520.4K	$547.1K	$1M	$1M	$2M	$1M	$870.2K	$942.7K
Operating Cash Flow	$-89M	$-104M	$-124M	$-216M	$-216M	$-178M	$-98M	$-74M	$-63M	$-63M	$-12M	$-30M
CapEx	$285.7K	$487.8K	$320.9K	$969.2K	$1M	$2M	$987.9K	$2M	$10M	$3M	$3M	$1M
Investing Cash Flow	$14M	$104M	$87M	$110M	$-175M	$-59M	$-9M	$42M	$-28M	$16M	$-55M	$-36M
Debt Issued	·	·	·	·	$0	$0	$97M	$0	$0	·	·	·
Net Debt Issued	·	·	·	·	$0	$0	$97M	·	·	·	·	·
Stock Issued	$35M	$36M	$5M	$83M	$209M	$454M	$9M	$29M	$94M	$6M	$82M	$59M
Net Stock Activity	$35M	$36M	$5M	$83M	$209M	$454M	$9M	$29M	$94M	$6M	$82M	$59M
Financing Cash Flow	$53M	$51M	$5M	$82M	$211M	$465M	$105M	$31M	$96M	$8M	$84M	$72M
Net Change in Cash	$-22M	$52M	$-32M	$-25M	$-180M	$229M	$-1M	$-92.9K	$5M	$-38M	$17M	$7M
Free Cash Flow	$-89M	$-105M	$-125M	$-217M	$-217M	$-179M	$-99M	$-76M	$-74M	$-65M	$-15M	$-31M
Levered FCF	·	·	$-126M	$-218M	$-219M	$-188M	$-107M	·	·	·	·	·

Redditività 7

Dati annuali Redditività per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	-132871.3%	-51616.9%	-17300.3%	-2607.3%	-16972.3%	-1674.2%	-2702.1%	-308.7%	-198.1%	-215.6%	-84.5%	-377.7%
Net Margin	-130000.0%	-49254.3%	-16239.9%	-2726.7%	-17109.9%	-2245.4%	-2902.8%	-318.1%	-208.9%	-208.5%	-71.9%	-345.4%
Pretax Margin	-130000.0%	-49254.3%	-16239.9%	-2705.6%	-17085.4%	-2197.9%	-2938.0%	-311.0%	-208.9%	-208.5%	-76.9%	·
EBITDA Margin	-132871.3%	-51616.9%	-17300.3%	-2607.3%	-16972.3%	-1674.2%	-2702.1%	-308.7%	-198.1%	-215.6%	-84.5%	-377.7%
ROA	-90.6%	-75.5%	-52.0%	-66.3%	-58.6%	-48.7%	-86.8%	-60.9%	-48.9%	-38.0%	-16.9%	-32.8%
ROE	-322.8%	-151.0%	-105.8%	-114.4%	-71.2%	-71.6%	-264.2%	-84.6%	-66.4%	-49.3%	-20.3%	-44.1%
ROIC	-360.3%	-164.1%	-122.7%	-120.3%	-75.4%	-26.9%	-3226.5%	-110.7%	-58.7%	-61.8%	-18.2%	·

Liquidità e Solvibilità 3

Dati annuali Liquidità e Solvibilità per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.4	2.8	3.6	3.3	6.8	11.3	2.9	2.5	3.9	2.8	5.5	7.1
Quick Ratio	1.3	2.7	3.4	2.6	6.2	10.3	2.8	2.4	3.8	2.8	5.4	6.9
Interest Coverage	·	·	-117.7	-213.4	-155.6	-14.3	-14.0	·	·	·	·	·

Efficienza 2

Dati annuali Efficienza per INO
Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.1
Receivables Turnover		0.1	0.1	·	2.9	0.1	0.8	2.0	6.5	3.9	3.1	8.0	3.4

Per Azione 5

Dati annuali Per Azione per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$0.35	$1.90	$5.15	$0.88	$1.84	$2.47	$0.03	$0.89	$1.58	$1.66	$2.43	$1.83
Revenue / Share	$0.00	$0.01	$0.04	$0.04	$0.01	·	$0.04	$0.33	$0.52	$0.48	$0.59	$0.18
Cash Flow / Share	$-1.89	$-3.83	$-5.61	$-0.91	$-1.03	·	$-0.99	$-0.79	$-0.77	$-0.85	$-0.18	$-0.50
Cash / Share	$0.64	$1.82	$0.63	$0.18	$0.33	$1.34	$0.22	$0.24	$0.26	$0.26	$0.80	$0.67
EPS (TTM)	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45	$-1.07	$-1.21	$-1.05	$-1.09	$-1.01	$-0.44	$-0.64

Tassi di Crescita 3

Dati annuali Tassi di Crescita per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-70.0%	-73.8%	-91.9%	478.2%	-76.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-81.5%	-50.3%	-51.8%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-61.2%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 10

Dati annuali Valutazione (TTM) per INO
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$65.3K	$217.8K	$832.0K	$10M	$2M	$7M	$4M	$30M	$42M	$35M	$41M	$10M
Net Income TTM	$-85M	$-107M	$-135M	$-280M	$-304M	$-166M	$-119M	$-97M	$-88M	$-74M	$-29M	$-36M
Market Cap	$120M	$66M	$139M	$4.74B	$13.02B	$19.84B	$4.01B	$4.67B	$4.48B	$6.17B	$5.82B	$6.69B
P/E	-1.0	-0.5	-1.0	-1.3	-3.4	-99.3	-32.7	-45.7	-45.5	-82.5	-183.3	-172.1
P/S	1837.3	303.4	167.7	461.7	7334.5	2677.5	976.2	153.1	106.1	174.4	143.5	639.9
P/B	5.0	1.0	1.2	21.3	32.6	43.0	1168.5	53.7	31.4	50.0	33.1	60.2
P / Tangible Book	5.0	1.0	1.2	22.6	33.7	44.3	·	·	·	·	·	·
P / Cash Flow	-1.4	-0.6	-1.1	-21.9	-60.3	-111.5	-41.0	-63.5	-70.8	-98.6	-468.2	-224.4
P / FCF	-1.4	-0.6	-1.1	-21.8	-60.0	-110.5	-40.6	-61.7	-60.9	-94.5	-382.6	-214.4
Earnings Yield	-104.0%	-215.9%	-99.5%	-75.2%	-29.1%	-1.0%	-3.1%	-2.2%	-2.2%	-1.2%	-0.55%	-0.58%

Conto Economico 15

Dati trimestrali Conto Economico per INO
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue	$0	$0	$0	$0	$0	$65.3K	$117.0K	$0	$100.8K	$0	$388.4K	$226.0K	$114.9K	$9M	$784.4K	$199.1K
R&D Expense	$11M	$14M	$10M	$13M	$15M	$16M	$13M	$19M	$23M	$21M	$16M	$24M	$30M	$33M	$56M	$56M
SG&A Expense	$8M	$8M	$7M	$8M	$9M	$9M	$8M	$9M	$10M	$11M	$10M	$14M	$14M	$12M	$48M	$16M
Operating Expenses	$19M	$22M	$17M	$21M	$23M	$25M	$20M	$27M	$33M	$31M	$36M	$37M	$44M	$45M	$105M	$72M
Operating Income	$-19M	$-22M	$-17M	$-21M	$-23M	$-25M	$-20M	$-27M	$-33M	$-31M	$-36M	$-37M	$-44M	$-36M	$-104M	$-72M
Interest Expense	·	·	·	·	·	·	·	·	·	$177.8K	$313.5K	$313.5K	$313.5K	$313.5K	$313.5K	$313.5K
Interest Income	$363.8K	$439.6K	$449.3K	$552.1K	$610.6K	$808.1K	$852.6K	$1M	$1M	$2M	$2M	$2M	$2M	$1M	$857.7K	$669.8K
Other Non-op	$-2M	$-285.5K	$88	$-2M	$-703.2K	$-482	$-2M	$-579.8K	$7.6K	$-682.2K	$2.9K	$-1M	$-2M	$-940.8K	$-3.0K	$-153.5K
Pretax Income	·	·	·	·	·	·	·	·	·	·	$-34M	$-36M	$-41M	$-38M	$-108M	$-77M
Net Income	$-6M	$-20M	$4M	$-45M	$-24M	$-20M	$-19M	$-25M	$-32M	$-30M	$-34M	$-36M	$-41M	$-38M	$-108M	$-79M
EPS (Basic)	$-0.07	$-0.28	$0.18	$-0.87	$-0.61	$-0.51	$-0.56	$-0.89	$-1.19	$-1.31	$-1.52	$-1.61	$-1.89	$-0.15	$-0.46	$-0.36
EPS (Diluted)	$-0.07	$-0.28	$0.18	$-0.87	$-0.61	$-0.51	$-0.56	$-0.89	$-1.19	$-1.31	$-1.52	$-1.61	$-1.89	$-0.15	$-0.46	$-0.36
Shares (Basic)	81,619,113	69,101,910	-82,725,987	52,168,694	38,830,053	38,613,653	-51,468,948	28,140,497	27,197,802	23,291,512	22,385,229	22,029,486	21,536,476	249,351,023	235,278,276	218,940,693
Shares (Diluted)	81,619,113	69,101,910	-82,725,987	52,168,694	38,830,053	38,613,653	-51,468,948	28,140,497	27,197,802	23,291,512	22,385,229	22,029,486	21,536,476	249,351,023	235,278,276	218,940,693
EBITDA	$-19M	$-22M	·	$-21M	$-23M	$-25M	·	$-27M	$-33M	$-31M	$-36M	$-37M	$-44M	$-36M	$-104M	$-72M

Stato Patrimoniale 25

Dati trimestrali Stato Patrimoniale per INO
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$32M	$26M	$44M	$37M	$24M	$40M	$66M	$22M	$34M	$20M	$19M	$53M	$28M	$22M	$41M	$59M
Short-term Investments	$5M	$11M	$14M	$14M	$23M	$28M	$28M	$63M	$76M	$86M	$149M	$142M	$196M	$260M	$307M	$301M
Receivables	·	·	$450	$978.6K	$840.3K	$1M	$1M	$2M	$2M	$3M	·	·	$73.3K	$2M	$4M	$4M
Prepaid Expense	$3M	$2M	$3M	$3M	$4M	$2M	$4M	$5M	$5M	$4M	$5M	$3M	$5M	$58M	$56M	$32M
Current Assets	$40M	$39M	$61M	$55M	$53M	$72M	$98M	$91M	$118M	$112M	$175M	$203M	$234M	$350M	$416M	$400M
PP&E (Net)	$2M	$2M	$3M	$3M	$3M	$3M	$4M	$4M	$5M	$5M	$6M	$6M	$7M	$16M	$16M	$17M
PP&E (Gross)	·	·	$20M	·	·	·	$20M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$17M	·	·	·	$16M	·	·	·	·	·	·	·	·	·
Goodwill	·	·	·	·	·	·	·	·	·	·	$0	$11M	$11M	$11M	$11M	$11M
Intangibles	·	·	·	·	·	·	·	·	·	·	$0	$0	$2M	$2M	$2M	$2M
Other Non-current Assets	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$566.4K	$585.9K	$605.3K	$605.3K	$666.9K	$652.5K	$702.0K	$770.1K	$1M
Total Assets	$49M	$50M	$74M	$69M	$68M	$87M	$113M	$107M	$134M	$129M	$193M	$233M	$267M	$392M	$459M	$446M
Accounts Payable	·	·	·	·	·	·	·	·	·	·	·	·	$25M	$74M	$105M	$38M
Current Liabilities	$40M	$38M	$44M	$70M	$32M	$27M	$35M	$23M	$26M	$23M	$44M	$52M	$55M	$95M	$131M	$59M
Capital Leases	$5M	$6M	$7M	$7M	$8M	$9M	$9M	$10M	$11M	$11M	$11M	$12M	$12M	$13M	$14M	$15M
Deferred Tax	·	·	·	·	·	·	·	·	·	·	$32.0K	$32.0K	$32.0K	$32.0K	$32.0K	$32.0K
Other Non-current Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	·	$710.3K	$0	$0
Total Liabilities	$45M	$44M	$50M	$77M	$40M	$36M	$45M	$34M	$37M	$35M	$55M	$64M	$67M	$125M	$162M	$90M
Common Stock	$82.3K	$69.8K	$69.0K	$53.6K	$36.7K	$36.7K	$36.1K	$26.1K	$26.0K	$23.4K	$269.7K	$268.1K	$262.7K	$249.5K	$247.5K	$226.5K
Paid-in Capital	$1.85B	$1.84B	$1.84B	$1.81B	$1.80B	$1.80B	$1.80B	$1.78B	$1.78B	$1.75B	$1.74B	$1.73B	$1.73B	$1.70B	$1.69B	$1.64B
Retained Earnings	$-1.84B	$-1.83B	$-1.82B	$-1.82B	$-1.77B	$-1.75B	$-1.73B	$-1.71B	$-1.69B	$-1.65B	$-1.60B	$-1.56B	$-1.53B	$-1.43B	$-1.40B	$-1.29B
AOCI	$-280.0K	$-636.1K	$-638.0K	$-647.4K	$-661.7K	$-661.3K	$-675.7K	$-623.5K	$-689.5K	$-676.2K	$-751.1K	$-691.3K	$-582.8K	$-885.2K	$-649.7K	$-457.9K
Stockholders' Equity	$4M	$6M	$24M	$-8M	$29M	$51M	$69M	$74M	$97M	$94M	$138M	$169M	$199M	$267M	$298M	$355M
Liabilities + Equity	$49M	$50M	$74M	$69M	$68M	$87M	$113M	$107M	$134M	$129M	$193M	$233M	$267M	$392M	$459M	$446M
Shares Outstanding	82,341,945	69,773,237	68,996,647	53,571,675	36,718,527	36,674,355	36,099,991	26,052,452	25,963,544	23,371,253	269,731,481	268,073,202	262,739,126	249,485,264	247,504,547	226,510,720

Flusso di cassa 10

Dati trimestrali Flusso di cassa per INO
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Stock-based Comp	$768.4K	$698.7K	$764.6K	$757.1K	$834.8K	$1M	$1M	$1M	$2M	$3M	$2M	$3M	$4M	$3M	$8M	$8M
Amort. of Intangibles	·	·	·	·	·	·	·	$0	$0	$0	$0	$63.3K	$82.1K	$120.0K	$131.0K	$126.8K
Operating Cash Flow	$-18M	$-22M	$-19M	$-22M	$-21M	$-27M	$-20M	$-27M	$-28M	$-29M	$-29M	$-32M	$-37M	$-67M	$-51M	$-62M
CapEx	$0	$0	$127.4K	$68.0K	$30.9K	$59.4K	$0	$0	$452.3K	$35.6K	$0	$23.9K	$297.0K	$86.8K	$717.2K	$0
Investing Cash Flow	$6M	$3M	$-58.2K	$9M	$5M	$-51.8K	$35M	$14M	$10M	$45M	$-5M	$54M	$19M	$45M	$-10M	$21M
Stock Issued	$3M	$1M	$27M	$7M	$0	$1M	$13M	$667.1K	$17M	$5M	$708.3K	$3M	$0	$4M	$43M	$29M
Net Stock Activity	·	$1M	·	·	·	$1M	·	·	·	$5M	·	·	$0	·	·	$29M
Financing Cash Flow	$17M	$953.8K	$27M	$25M	$-34.8K	$1M	$29M	$660.6K	$33M	$-11M	$698.6K	$3M	$-424.7K	$4M	$43M	$28M
Net Change in Cash	$5M	$-18M	$8M	$12M	$-16M	$-26M	$44M	$-13M	$15M	$5M	$-34M	$24M	$-18M	$-19M	$-18M	$-12M
Free Cash Flow	·	$-22M	·	·	·	$-27M	·	·	·	$-29M	·	·	$-37M	·	·	$-62M

Redditività 6

Dati trimestrali Redditività per INO
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Operating Margin	·	·	·	·	·	-38337.0%	·	·	-32945.9%	·	-9152.6%	-16392.0%	-38238.2%	-390.6%	-13276.1%	-36033.3%
Net Margin	·	·	·	·	·	-30140.5%	·	·	-31993.3%	·	-8734.8%	-15725.3%	-35364.8%	-412.8%	-13832.0%	-39720.8%
Pretax Margin	·	·	·	·	·	·	·	·	·	·	-8734.8%	-15725.3%	-35364.8%	-412.8%	-13832.0%	-38633.1%
EBITDA Margin	·	·	·	·	·	-38337.0%	·	·	-32945.9%	·	-9152.6%	-16392.0%	-38238.2%	-390.6%	-13276.1%	-36033.3%
ROA	-10.2%	-28.7%	·	-51.6%	-23.3%	-18.2%	·	-16.8%	-17.6%	-15.4%	-11.6%	-10.3%	-11.4%	-8.2%	-20.6%	-14.4%
ROE	-36.5%	-68.7%	·	-138.2%	-37.5%	-27.0%	·	-23.8%	-24.2%	-20.8%	-16.8%	-15.2%	-14.7%	-10.5%	-26.9%	-16.9%

Liquidità e Solvibilità 3

Dati trimestrali Liquidità e Solvibilità per INO
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio	1.0	1.0	·	0.8	1.7	2.6	·	3.9	4.5	4.8	4.0	3.9	4.2	3.7	3.2	6.7
Quick Ratio	0.9	1.0	·	0.7	1.5	2.5	·	3.7	4.2	4.6	3.8	3.8	4.1	3.0	2.7	6.1
Interest Coverage	·	·	·	·	·	·	·	·	·	-177.0	-113.4	-118.2	-140.2	-114.1	-332.2	-228.8

Efficienza 2

Dati trimestrali Efficienza per INO
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Receivables Turnover		·	·	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	·	0.1	2.5	0.1	0.0

Per Azione 5

Dati trimestrali Per Azione per INO
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$0.05	$0.09	·	$-0.14	$0.78	$1.40	·	$2.82	$3.73	$4.04	$0.51	$0.63	$0.76	$1.07	$1.20	$1.57
Revenue / Share	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.04	$0.00	$0.00
Cash Flow / Share	·	$-0.31	·	·	·	$-0.70	·	·	·	$-1.23	·	·	$-0.14	·	·	$-0.28
Cash / Share	$0.38	$0.38	·	$0.68	$0.66	$1.09	·	$0.83	$1.32	$0.84	$0.07	$0.20	$0.11	$0.09	$0.17	$0.26
EPS (TTM)	$-1.83	$-2.27	·	$-2.88	$-3.20	$-3.90	·	$-4.91	$-5.63	$-6.33	$-5.17	$-4.11	$-2.86	$-1.26	$-1.50	$-1.31

Valutazione (TTM) 10

Dati trimestrali Valutazione (TTM) per INO
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$0	$65.3K	·	$65.3K	$166.1K	$166.1K	·	$489.2K	$715.2K	$729.4K	$10M	$10M	$10M	$10M	$2M	$1M
Net Income TTM	$-95M	$-108M	·	$-114M	$-101M	$-108M	·	$-122M	$-132M	$-141M	$-148M	$-222M	$-266M	$-286M	$-330M	$-276M
Market Cap	$91M	$121M	·	$125M	$75M	$60M	·	$151M	$210M	$324M	$1.26B	$1.45B	$2.59B	$5.18B	$5.14B	$9.76B
P/E	-0.6	-0.8	·	-0.8	-0.6	-0.4	·	-1.2	-1.4	-2.2	-0.9	-1.3	-3.4	-16.5	-13.8	-32.9
P/S	·	1858.0	·	1918.5	451.0	359.9	·	307.8	293.3	444.8	127.7	140.8	252.2	496.6	3319.3	8599.6
P/B	20.7	20.0	·	-16.2	2.6	1.2	·	2.0	2.2	3.4	9.1	8.5	13.0	19.4	17.3	27.5
P / Tangible Book	20.7	20.0	·	·	2.6	1.2	·	2.0	2.2	3.4	9.1	9.1	13.9	20.4	18.0	28.5
P / Cash Flow	·	-5.6	·	·	·	-2.2	·	·	·	-11.3	·	·	-70.5	·	·	-157.7
P / FCF	·	-5.6	·	·	·	-2.2	·	·	·	-11.3	·	·	-69.9	·	·	-157.7
Earnings Yield	-166.4%	-130.5%	·	-123.1%	-156.9%	-239.3%	·	-85.0%	-69.7%	-45.6%	-110.5%	-76.1%	-29.1%	-6.1%	-7.2%	-3.0%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$65.3K	$217.8K	$832.0K	$10M	$2M
Margine Operativo %	-132871.3%	-51616.9%	-17300.3%	-2607.3%	-16972.3%
Utile netto	$-85M	$-107M	$-135M	$-280M	$-304M
EPS Diluito	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	1.4	2.8	3.6	3.3	6.8
Quick Ratio	1.3	2.7	3.4	2.6	6.2

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-89M	$-105M	$-125M	$-217M	$-217M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 119 filer · $38.3M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
27 (+11 vs trimestre precedente)	15 (+2 vs trimestre precedente)	30 (+7 vs trimestre precedente)	15 (-10 vs trimestre precedente)	+1.7M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
FMR LLC	$9.300.258	8.454.780	24,27%	Azioni
JANUS HENDERSON GROUP PLC	$5.773.168	3.308.406	15,06%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$4.015.618	3.650.562	10,48%	Azioni
Boxer Capital Management, LLC	$3.129.493	2.844.994	8,17%	Azioni
ADAR1 Capital Management, LLC	$2.358.301	2.143.910	6,15%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.672.440	1.520.400	4,36%	Opzione Call
D. E. Shaw & Co., Inc.	$1.486.822	1.351.656	3,88%	Azioni
TWO SIGMA INVESTMENTS, LP	$1.363.756	1.239.778	3,56%	Azioni
Eversept Partners, LP	$1.138.896	1.035.360	2,97%	Azioni
MILLENNIUM MANAGEMENT LLC	$875.718	796.107	2,29%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$711.196	645.884	1,86%	Azioni
VANGUARD GROUP INC	$682.195	392.066	1,78%	Azioni
VANGUARD FIDUCIARY TRUST CO	$528.846	480.769	1,38%	Azioni
Caption Management, LLC	$526.845	478.950	1,37%	Azioni
Caption Management, LLC	$440.000	400.000	1,15%	Opzione Call
RENAISSANCE TECHNOLOGIES LLC	$397.473	361.339	1,04%	Azioni
STATE STREET CORP	$370.271	336.610	0,97%	Azioni
CITADEL ADVISORS LLC	$351.450	319.500	0,92%	Opzione Call
TUDOR INVESTMENT CORP ET AL	$330.000	300.000	0,86%	Opzione Call
DIADEMA PARTNERS LP	$302.720	275.200	0,79%	Opzione Call
Quadrature Capital Ltd	$284.821	258.928	0,74%	Azioni
NORTHERN TRUST CORP	$191.785	174.350	0,50%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$190.300	173.000	0,50%	Azioni
NOMURA HOLDINGS INC	$165.000	150.000	0,43%	Azioni
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	$147.012	133.648	0,38%	Azioni
GMT Capital Corp	$138.731	126.119	0,36%	Azioni
JANE STREET GROUP, LLC	$135.953	123.594	0,35%	Azioni
TWO SIGMA ADVISERS, LP	$128.240	73.701	0,33%	Azioni
XTX Topco Ltd	$116.416	105.833	0,30%	Azioni
GOLDMAN SACHS GROUP INC	$103.092	93.720	0,27%	Azioni
CITADEL ADVISORS LLC	$92.620	84.200	0,24%	Opzione Put
Invesco Ltd.	$88.372	80.338	0,23%	Azioni
Green Alpha Advisors, LLC	$74.861	68.055	0,20%	Azioni
JANE STREET GROUP, LLC	$71.940	65.400	0,19%	Opzione Call
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$63.690	57.900	0,17%	Opzione Put
MORGAN STANLEY	$48.980	44.527	0,13%	Azioni
RAYMOND JAMES FINANCIAL INC	$44.306	40.278	0,12%	Azioni
Squarepoint Ops LLC	$40.030	36.391	0,10%	Azioni
Engineers Gate Manager LP	$37.060	33.691	0,10%	Azioni
Vanguard Global Advisers, LLC	$33.259	30.235	0,09%	Azioni
Headlands Technologies LLC	$32.878	29.889	0,09%	Azioni
CITADEL ADVISORS LLC	$32.034	29.122	0,08%	Azioni
ZACKS INVESTMENT MANAGEMENT	$29.079	26.435	0,08%	Azioni
Nuveen Asset Management, LLC	$22.004	12.024	0,06%	Azioni
BlackRock, Inc.	$20.770	18.882	0,05%	Azioni
Prime Capital Investment Advisors, LLC	$18.839	17.126	0,05%	Azioni
LPL Financial LLC	$18.826	17.114	0,05%	Azioni
StoneX Group Inc.	$18.077	14.252	0,05%	Azioni
Persistent Asset Partners Ltd	$17.885	511	0,05%	Opzione Call
TWO SIGMA SECURITIES, LLC	$17.554	15.958	0,05%	Azioni
STEPHENS INC /AR/	$17.050	15.500	0,04%	Azioni
AXQ CAPITAL, LP	$15.249	13.863	0,04%	Azioni
Tower Research Capital LLC (TRC)	$14.631	13.301	0,04%	Azioni
HighTower Advisors, LLC	$14.003	12.730	0,04%	Azioni
Mayflower Financial Advisors, LLC	$13.815	12.559	0,04%	Azioni
MCF Advisors LLC	$12.402	11.274	0,03%	Azioni
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC	$12.131	11.028	0,03%	Azioni
Caitong International Asset Management Co., Ltd	$11.024	10.022	0,03%	Azioni
SBI Securities Co., Ltd.	$7.495	6.814	0,02%	Azioni
BARCLAYS PLC	$3.836	3.487	0,01%	Azioni
ROYAL BANK OF CANADA	$3.000	3.011	0,01%	Azioni
TD Waterhouse Canada Inc.	$2.812	2.383	0,01%	Azioni
Rockefeller Capital Management L.P.	$2.313	2.103	0,01%	Azioni
Activest Wealth Management	$1.650	1.500	0,00%	Azioni
Steward Partners Investment Advisory, LLC	$1.519	1.381	0,00%	Azioni
Optiver Holding B.V.	$1.458	1.325	0,00%	Azioni
CROWLEY WEALTH MANAGEMENT, INC.	$945	404	0,00%	Azioni
IFG Advisory, LLC	$917	833	0,00%	Azioni
Integrated Wealth Concepts LLC	$584	529	0,00%	Azioni
OSAIC HOLDINGS, INC.	$578	529	0,00%	Azioni
NFSG Corp	$394	359	0,00%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$387	352	0,00%	Azioni
MJT & Associates Financial Advisory Group, Inc.	$358	325	0,00%	Azioni
PNC Financial Services Group, Inc.	$330	300	0,00%	Azioni
Pioneer Family Office, LLC	$320	291	0,00%	Azioni
WELLS FARGO & COMPANY/MN	$305	277	0,00%	Azioni
GSA CAPITAL PARTNERS LLP	$292	265.011	0,00%	Azioni
VSM Wealth Advisory, LLC	$275	250	0,00%	Azioni
JONES FINANCIAL COMPANIES LLLP	$264	240	0,00%	Azioni
HARBOUR INVESTMENTS, INC.	$261	237	0,00%	Azioni
CWM, LLC	$254	146	0,00%	Azioni
Decker Retirement Planning Inc.	$185	168	0,00%	Azioni
Federation des caisses Desjardins du Quebec	$155	141	0,00%	Azioni
HRT FINANCIAL LP	$154	140.432	0,00%	Azioni
UBS Group AG	$141	128	0,00%	Azioni
Farther Finance Advisors, LLC	$122	111	0,00%	Azioni
Arax Advisory Partners	$113	103	0,00%	Azioni
MERCER GLOBAL ADVISORS INC /ADV	$109	99	0,00%	Azioni
Aberdeen Wealth Management LLC	$100	91	0,00%	Azioni
Smartleaf Asset Management LLC	$93	83	0,00%	Azioni
Blume Capital Management, Inc.	$92	83	0,00%	Azioni
PITTENGER & ANDERSON INC	$85	77	0,00%	Azioni
Ameritas Investment Partners, Inc.	$70	64	0,00%	Azioni
MCDONALD PARTNERS LLC	$64	58	0,00%	Azioni
NATIONAL BANK OF CANADA /FI/	$64	58	0,00%	Azioni
JPMORGAN CHASE & CO	$52	46	0,00%	Azioni
Allworth Financial LP	$52	47	0,00%	Azioni
1 NORTH WEALTH SERVICES LLC	$45	41	0,00%	Azioni
Pinnacle Wealth Planning Services, Inc.	$45	41	0,00%	Azioni
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC	$43	36	0,00%	Azioni

Insider aziendali 42 insider · 12 dirigenti · 24 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Netto 12m
Jacqueline Elizabeth Shea	Chief Executive Officer	20 Maggio 2025 A	59.685	$0
Jong Joseph Kim	Chief Executive Officer	11 Marzo 2022 M	1.422.627	$0
Niranjan Sardesai	Chief Operating Officer	10 Marzo 2018 M	123.486	$0
Michael John Sumner	Chief Medical Officer	30 Giugno 2025 M	17.850	$0
Laurent Humeau	Chief Scientific Officer	20 Maggio 2025 A	32.622	$0
Mark Bagarazzi	Chief Medical Officer	05 Marzo 2019 M	100.672	$0
Kevin Rassas	Sr. VP Business Development	16 Novembre 2009 M	726.088	$0
Cheryl Jo White	Chief Medical Officer	29 Giugno 2009 M	—	$0
Dietmar P Rabussay	V.P. Research & Development	08 Marzo 2007 A	17.386	$0
Robert S Goodenew	V.P. Corporate Development	20 Dicembre 2006 M	—	$0
George F. Mchugh III	Vice President, Operations	08 Marzo 2006 A	1	$0
Brook G Riggins	V.P. Finance & Corp. Comm.	07 Novembre 2003 A	—	$0
Wendy L Yarno	Direttore	20 Maggio 2026 A	10.512	$0
Ann Calby Miller	Direttore	21 Maggio 2025 M	9.877	$0
Roger D Dansey	Direttore	21 Maggio 2025 M	8.916	$0
David B. Weiner	Direttore	21 Maggio 2025 M	86.620	$0
Jay Shepard	Direttore	21 Maggio 2025 M	9.209	$0
Angel Cabrera	Direttore	08 Maggio 2020 M	75.602	$0
Morton Collins	Direttore	11 Maggio 2019 M	168.130	$0
Avtar S Dhillon	Direttore	06 Dicembre 2018 M	106.002	$0
Adel Mahmoud	Direttore	12 Maggio 2018 M	22.669	$0
George Bickerstaff	Direttore	21 Marzo 2018 M	4.090	$0
Nancy Wysenski	Direttore	13 Maggio 2016 A	5.000	$0
Keith H Wells	Direttore	13 Maggio 2011 A	—	$0
David J Williams	Direttore	16 Giugno 2010 A	—	$0
Chin Cheong Chong	Direttore	09 Dicembre 2008 A	—	$0
James L Heppell	Direttore	14 Agosto 2008 A	2	$0
Stephen Rietiker	Direttore	02 Maggio 2008 A	—	$0
Robert William Rieder	Direttore	02 Maggio 2008 A	—	$0
Riaz Amirali Bandali	Direttore	02 Maggio 2008 A	2	$0
Tazdin Esmail	Direttore	02 Maggio 2008 A	2	$0
Felix Theeuwes	Direttore	07 Giugno 2006 A	2	$0
Eugene A Larson	Direttore	13 Maggio 2005 A	3	$0
Gordon Politeski	Direttore	08 Agosto 2003 A	—	$0
MARXE AUSTIN W & GREENHOUSE DAVID M	Proprietario del 10%	03 Dicembre 2012 S	3.919.706	$0
Lota S. Zoth	—	20 Maggio 2026 A	8.726	$0
Simon X Benito	—	20 Maggio 2026 A	12.191	$0
Peter Kies	—	20 Maggio 2026 A	42.854	$0
Tee Khiang Ng	—	30 Settembre 2009 A	—	$0
Punit Dhillon	—	30 Settembre 2009 A	—	$0
Michael Fons	—	30 Settembre 2009 A	—	$0
Beng Lee Gan	—	02 Maggio 2008 A	—	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 2 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Dr. J. Joseph Kim	10 Giugno 2009	—	Deposito iniziale	—	SEC
Simon Benito, Tee Khiang Ng and Morton Collins, Voting Trustees Under Voting Trust Agreement Dated June 1, 2009 among the Issuer, the Voting Trustees and the Stockholders listed therein.	10 Giugno 2009	—	Deposito iniziale	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 4 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,25%	85.360 SH	08 Agosto 2026	Giornaliero
IWC · iShares Trust	0,01%	280.138 SH	08 Agosto 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,00%	963.325 SH	08 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	2.600.092 SH	08 Agosto 2026	Giornaliero

Informazioni su Inovio Pharmaceuticals, Inc. - Common Stock Panoramica della società da Wikipedia

INO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

INO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

INO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 119 filer · $38.3M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 42 insider · 12 dirigenti · 24 direttori

Attivisti e proprietari del 5%+ 2 partecipazioni

Proprietà ETF Posseduti da 4 ETF